Impact of KRAS Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based Chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of KRAS Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based Chemotherapy

Published:2011-08-23 Issue:10 Volume:10 Page:1993-1999
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Kim Seung Tae,Lim Do Hyoung,Jang Kee-Taek,Lim Taekyu,Lee Jeeyun,Choi Yoon-La,Jang Hye-Lim,Yi Jun Ho,Baek Kyung Kee,Park Se Hoon,Park Young Suk,Lim Ho Yeong,Kang Won Ki,Park Joon Oh

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers;International Journal of Molecular Sciences;2024-08-02

2. Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment;Frontiers in Oncology;2024-05-10

3. Genomic determinants of biological aggressiveness and poor prognosis of pancreatic cancers: KRAS and beyond;Expert Review of Molecular Diagnostics;2024-05-03

4. Metabolomic Approach to Identify Potential Biomarkers in KRAS-Mutant Pancreatic Cancer Cells;Biomedicines;2024-04-15

5. Genetic Signature of Human Pancreatic Cancer and Personalized Targeting;Cells;2024-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP